Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial

BACKGROUND: Management of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remains a clinical challenge. Currently, riociguat, a soluble guanylate-cyclase stimulator is recommended by international guidelines. More recently, balloon pulmonary angioplasty (BPA) develops as an alternat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qin-Hua, Gong, Su-Gang, He, Jing, Yuan, Ping, Wu, Wen-Hui, Luo, Ci-Jun, Jiang, Rong, Zhang, Rui, Qiu, Hong-Ling, Li, Hui-Ting, Li, Yuan, Liu, Jin-Ming, Wang, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711204/
https://www.ncbi.nlm.nih.gov/pubmed/34961562
http://dx.doi.org/10.1186/s13063-021-05910-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711204/
https://www.ncbi.nlm.nih.gov/pubmed/34961562
http://dx.doi.org/10.1186/s13063-021-05910-5

Ejemplares similares